Prednisolone may increase the risk of peptic ulceration and gastritis, particularly when used long-term, at higher doses, or concurrently with NSAIDs
FDA Drug Shortages: Semaglutide
When combined, the appetite-suppressing effect of Ozempic dominates
However, the individual evidence for each compound is so robust, and the mechanisms so complementary, that the case for combining them is strong
They determined that those prescribed GLP-1 agonists exhibit a significantly lower risk of developing RVO over five years, particularly for branch RVO (BRVO), compared to those on DPP-4 inhibitors, which could contribute to favorable long-term ocular outcomes and reduce the burden of visual impairment with this treatment option in this population
Semaglutide, a mimic of glucagon-like peptide-1 (GLP-1), has garnered approval for managing type 2 diabetes (both orally and via subcutaneous injection) and for mitigating cardiovascular risks in those with type 2 diabetes and cardiovascular ailments (specifically through subcutaneous injection)